(株)リボミックの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4591/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/07/01 | 日証協 | 317,300株 | -0.72% | 16,703株 | +23.73% | 391,253株 | -4.54% | 12,600株 | +46.34% |
2016/06/24 | 日証協 | 319,600株 | -1.11% | 13,500株 | -57.01% | 409,854株 | -0.39% | 8,610株 | -75.12% |
2016/06/17 | 日証協 | 323,200株 | -18.05% | 31,400株 | +159.5% | 411,444株 | -5.31% | 34,610株 | +43.02% |
2016/06/10 | 日証協 | 394,400株 | -7.24% | 12,100株 | -36.98% | 434,534株 | -0.32% | 24,200株 | -4.35% |
2016/06/03 | 日証協 | 425,200株 | -0.54% | 19,200株 | -82.53% | 435,934株 | -3.69% | 25,300株 | -27.92% |
2016/05/27 | 日証協 | 427,500株 | -13.98% | 109,900株 | +105.04% | 452,634株 | -4.13% | 35,100株 | +70.39% |
2016/05/20 | 日証協 | 497,000株 | +9.52% | 53,600株 | +30.73% | 472,134株 | -0.78% | 20,600株 | -45.23% |
2016/05/13 | 日証協 | 453,800株 | +4.39% | 41,000株 | +236.07% | 475,824株 | +1% | 37,610株 | +478.62% |
2016/05/06 | 日証協 | 434,700株 | -2.82% | 12,200株 | +125.93% | 471,124株 | -1.92% | 6,500株 | -79.3% |
2016/04/28 | 日証協 | 447,300株 | -6.54% | 5,400株 | -82.3% | 480,324株 | +0.15% | 31,400株 | +36.52% |
2016/04/22 | 日証協 | 478,600株 | +7.19% | 30,500株 | -13.6% | 479,624株 | +10.13% | 23,000株 | -35.61% |
2016/04/15 | 日証協 | 446,500株 | -5.8% | 35,300株 | -39.55% | 435,524株 | -11.13% | 35,720株 | -43.56% |
2016/04/08 | 日証協 | 474,000株 | +6.59% | 58,400株 | +472.55% | 490,084株 | +9.12% | 63,285株 | +33.73% |
2016/04/01 | 日証協 | 444,700株 | -6.93% | 10,200株 | -81.56% | 449,124株 | -4.06% | 47,323株 | +9.54% |
2016/03/25 | 日証協 | 477,800株 | -3.57% | 55,300株 | +1102.17% | 468,124株 | +6.17% | 43,200株 | +110.53% |
2016/03/18 | 日証協 | 495,500株 | -5.06% | 4,600株 | -74.44% | 440,924株 | -1.82% | 20,520株 | -9.36% |
2016/03/11 | 日証協 | 521,900株 | -6.74% | 18,000株 | +2150% | 449,104株 | -0.59% | 22,640株 | +495.79% |
2016/03/04 | 日証協 | 559,600株 | +11.19% | 800株 | -82.61% | 451,778株 | +8.42% | 3,800株 | +18.75% |
2016/02/26 | 日証協 | 503,300株 | -19.23% | 4,600株 | -91.96% | 416,678株 | -13.42% | 3,200株 | -57.39% |
※株式分割は考慮していませんのでご注意ください。
Page Top